The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide, accounting for an estimated 600,000 deaths annually. Aberrant methylation, consisting of DNA hypomethylation and/or promoter gene CpG hypermethylation, is implicated in the development of a variety of solid tumors, including HCC. We analyzed the global levels of DNA methylation as well as the methylation status of 105 putative tumor suppressor genes and found that the extent of genome-wide hypomethylation and CpG hypermethylation correlates with biological features and clinical outcome of HCC patients. We identified activation of Ras and downstream Ras effectors (ERK, AKT, and RAL) due to epigenetic silencing of inhibitors of the Ras pathway in all HCC. Further, selective inactivation of SPRY1 and -2, DAB2, and SOCS4 and -5 genes and inhibitors of angiogenesis (BNIP3, BNIP3L, IGFBP3, and EGLN2) was associated with poor prognosis. Importantly, several epigenetically silenced putative tumor suppressor genes found in HCC were also inactivated in the nontumorous liver. Our results assign both therapeutic and chemopreventive significance to methylation patterns in human HCC and open the possibility of using molecular targets, including those identified in this study, to effectively inhibit HCC development and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Self-citationMutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer
Kosaka, T., Yatabe, Y., Endoh, H., Kuwano, H., Takahashi, T., & Mitsudomi, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2818 · Cited by 1,228
COBRA: a sensitive and quantitative DNA methylation assay
Xiong, Z., & Laird, P. W. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2532 · Cited by 1,195
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
Suzuki, H., Watkins, D. N., Jair, K.-W., Schuebel, K. E., Markowitz, S. D., Dong Chen, W., Pretlow, T. P., Yang, B., Akiyama, Y., van Engeland, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1330 · Cited by 1,069
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Self-citationRobertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
Oncogenic PI3K deregulates transcription and translation
Bader, A. G., Kang, S., Zhao, L., & Vogt, P. K. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1753 · Cited by 798
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Self-citationFocus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
Lee, J.-S., Chu, I.-S., Mikaelyan, A., Calvisi, D. F., Heo, J., Reddy, J. K., & Thorgeirsson, S. S. (2004) · Nature Genetics · doi:10.1038/ng1481 · Cited by 475
Self-citationModulation of signalling by Sprouty: a developing story
Kim, H. J., & Bar-Sagi, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1400 · Cited by 372
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
Yang, B., Guo, M., Herman, J. G., & Clark, D. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63469-4 · Cited by 365
Atienzar, F. A., & Jha, A. N. (2006) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.06.001 · Cited by 355
A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann, D. A., Seftor, E. A., Fong, S. F. T., Nieva, D. R. C., Sullivan, C. M., Edwards, E. M., Sommer, P., Csiszar, K., & Hendrix, M. J. C. (2002) · PubMed · Cited by 338
The epigenetics of cancer etiology
Feinberg, A. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.005 · Cited by 337
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J.-H., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 330
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Repasky, G. A., Chenette, E. J., & Der, C. J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.014 · Cited by 300
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
Fransen, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh049 · Cited by 268
Jiang, W. B., Kahn, S. M., Guillem, J. G., Lu, S. H., & Weinstein, I. B. (1989) · PubMed · Cited by 267
DNA Hypomethylation and Ovarian Cancer Biology
Widschwendter, M., Jiang, G., Woods, C., Müller, H. M., Fiegl, H., Goebel, G., Marth, C., Müller-Holzner, E., Zeimet, A. G., Laird, P. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0238 · Cited by 254
Differential hypermethylation of SOCS genes in ovarian and breast carcinomas
Sutherland, K. D., Lindeman, G. J., Choong, D. Y. H., Wittlin, S., Brentzell, L., Phillips, W., Campbell, I. G., & Visvader, J. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207787 · Cited by 217
Saito, Y., Kanai, Y., Sakamoto, M., Saito, H., Ishii, H., & Hirohashi, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152121799 · Cited by 214
Egger, G., Jeong, S., Escobar, S. G., Cortez, C. C., Li, T. W. H., Saito, Y., Yoo, C. B., Jones, P. A., & Liang, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604602103 · Cited by 207
Pogribny, I., Yi, P., & James, S. J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1187 · Cited by 197
Du, Y., Carling, T., Fang, W., Piao, Z. H., Sheu, J., & Huang, S. (2001) · PubMed · Cited by 189
Soares, J., Pinto, A. E., Cunha, C. V., Andr�, S., Bar�o, I., Sousa, J. M., & Cravo, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<112::aid-cncr16>3.0.co;2-t · Cited by 187
DNA methylation and cancer therapy: new developments and expectations
Esteller, M. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000147383.04709.10 · Cited by 183
Yu, J., Ni, M., Xu, J., Zhang, H., Gao, B., Gu, J., Chen, J., Zhang, L., Wu, M., Zhen, S., et al. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-29 · Cited by 170
Yoshida, T., Hisamoto, T., Akiba, J., Koga, H., Nakamura, K., Tokunaga, Y., Hanada, S., Kumemura, H., Maeyama, M., Harada, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209635 · Cited by 169
Stimulation of angiogenesis by Ras proteins
Kranenburg, O., Gebbink, M. F. B. G., & Voest, E. E. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.004 · Cited by 168
Kaneda, A., Wakazono, K., Tsukamoto, T., Watanabe, N., Yagi, Y., Tatematsu, M., Kaminishi, M., Sugimura, T., & Ushijima, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1543 · Cited by 163
Regulation of the Promoter Activity of Interferon Regulatory Factor-7 Gene
Lu, R., Au, W.-C., Yeow, W.-S., Hageman, N., & Pitha, P. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005288200 · Cited by 163
Sato, N., Fukushima, N., Chang, R., Matsubayashi, H., & Goggins, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.008 · Cited by 162
Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal Growth Factor Receptor Signaling
Kario, E., Marmor, M. D., Adamsky, K., Citri, A., Amit, I., Amariglio, N., Rechavi, G., & Yarden, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408575200 · Cited by 151
Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer
McKie, A. B., Douglas, D. A., Olijslagers, S., Graham, J., Omar, M. M., Heer, R., Gnanapragasam, V. J., Robson, C. N., & Leung, H. Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208371 · Cited by 139
Santoni‐Rugiu, E., Jensen, M. R., & Thorgeirsson, S. S. (1998) · PubMed · Cited by 123
Self-citationJian, Y. U., Zhang, H. Y., Zhong, Z., Lu, W., Wang, Y., & Jingde, Z. H. U. (2003) · Cell Research · doi:10.1038/sj.cr.7290177 · Cited by 115
Distinct methylation profiles of glioma subtypes
Uhlmann, K., Rohde, K., Zeller, C., Szymaś, J., Vogel, S., Marczinek, K., Thiel, G., Nürnberg, P., & Laird, P. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11175 · Cited by 114
Calvisi, D. F., Factor, V. M., Loi, R., & Thorgeirsson, S. S. (2001) · PubMed · Cited by 112
Self-citationHypermethylation in Histologically Distinct Classes of Breast Cancer
Bae, Y. K., Brown, A. L., Garrett, E., Bornman, D. M., Fackler, M. J., Sukumar, S. V., Herman, J. G., & Gabrielson, E. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0667 · Cited by 112
Nicholson, S. E., Metcalf, D., Sprigg, N. S., Columbus, R., Walker, F., Silva, A., Cary, D., Willson, T. A., Zhang, J., Hilton, D. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409675102 · Cited by 112
Lee, J., & Thorgeirsson, S. S. (2002) · Hepatology · doi:10.1053/jhep.2002.33165 · Cited by 111
Self-citationCalvisi, D. F., Factor, V. M., Ladu, S., Conner, E. A., & Thorgeirsson, S. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.014 · Cited by 100
Self-citationMechanisms underlying epigenetically mediated gene silencing in cancer
Baylin, S. B. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00053-6 · Cited by 100
Lim, J.-H., Lee, E.-S., You, H. J., Lee, S. E., Park, J., & Chun, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1208003 · Cited by 100
Angiostatic activity of DNA methyltransferase inhibitors
Hellebrekers, D. M. E. I., Jair, K.-W., Viré, E. A., Eguchi, S., Hoebers, N., Fraga, M. F., Esteller, M., Fuks, F., Baylin, S. B., van Engeland, M., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0417 · Cited by 99
Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells
Kim, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh912 · Cited by 89
Zhou, J., Scholes, J., & Hsieh, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210628200 · Cited by 75
DNMT1 knockout delivers a strong blow to genome stability and cell viability
Brown, K. D., & Robertson, K. D. (2007) · Nature Genetics · doi:10.1038/ng0307-289 · Cited by 60
Irimia, M., Fraga, M. F., Sánchez‐Céspedes, M., & Esteller, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207914 · Cited by 58
Wang, S., Makino, K., Xia, W., Kim, J. S., Im, S., Peng, H., Mok, S. C., Singletary, S. E., & Hung, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204873 · Cited by 53
He, J., Smith, E. R., & Xu, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101820200 · Cited by 46
RRP22 Is a Farnesylated, Nucleolar, Ras-Related Protein with Tumor Suppressor Potential
Elam, C. A., Hesson, L. B., Vos, M. D., Eckfeld, K., Ellis, C. A., Bell, A., Krex, D., Birrer, M. J., Latif, F., & Clark, G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0749 · Cited by 40
Epigenetic Changes in Cancer and PreneoplasiaPreprint
Herman, J. G. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.036 · Cited by 27
Cited by
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
SOCS regulation of the JAK/STAT signalling pathway
Croker, B. A., Kiu, H., & Nicholson, S. E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.010 · Cited by 611
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Rebouissou, S., & Nault, J.-C. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.017 · Cited by 575
Steelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, C. R., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., et al. (2011) · Aging · doi:10.18632/aging.100296 · Cited by 553
Metadata
- Authors
- Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Lee, J.-S., Conner, E. A., Schroeder, I., Factor, V. M., & Thorgeirsson, S. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-09-04
- Volume
- 117
- Issue
- 9
- Pages
- 2713-2722
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2114973741
- Cited by
- 393
- References
- 72
- FWCI
- 11.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.